Loading...
XSHE300453
Market cap502mUSD
Jan 10, Last price  
7.16CNY
1D
-2.05%
1Q
-3.37%
Jan 2017
-1.23%
IPO
130.39%
Name

Jiangxi Sanxin Medtec Co Ltd

Chart & Performance

D1W1MN
XSHE:300453 chart
P/E
17.81
P/S
2.83
EPS
0.40
Div Yield, %
1.62%
Shrs. gr., 5y
-0.32%
Rev. gr., 5y
19.60%
Revenues
1.30b
-2.69%
220,401,905280,442,903304,737,396322,204,633311,848,211317,774,431403,871,872531,302,358721,668,064940,385,5891,164,288,7631,336,002,6471,300,060,980
Net income
207m
+11.92%
35,026,82147,697,58048,642,65948,615,38351,876,39936,613,95542,389,56041,145,67061,683,106115,624,846155,910,663184,634,263206,633,857
CFO
346m
-13.93%
34,434,00041,264,88130,005,64768,291,52262,880,19061,303,42162,262,10058,886,773167,355,013272,895,487329,716,957402,176,397346,149,480
Dividend
Sep 09, 20240.1 CNY/sh
Earnings
Apr 16, 2025

Profile

Jiangxi Sanxin Medtec Co., Ltd. engages in the research and development, manufacture, sale, and service of medical devices in China and internationally. It offers blood purification products, such as centralized dialysate supply systems, hemodialysis water preparation systems, hemodialysis machines, nursing kits for dialysis, central venous catheter packs, arteriovenous spikes, accessories tubing for HDF, dialysate filters, hemodialysis powders and concentrates, hollow fiber hemodialyzers, sterile hemodialysis blood circuits, and tubing sets for hemodialysis. The company also provides infusion and transfusion products, including light-resistant infusion sets, TPE precise filter infusion sets, auto stop fluid precise filter infusion sets, transfusion sets, catheter infusion sets, and precise filter light resistant infusion sets; injections consisting of insulin, dispenser, sterile, and auto-disable syringes; and syringes for fixed dose immunization, hypodermic needles, needleless injection systems, and pneumatic syringes. In addition, it offers indwelling catheter products comprising straight, Y-type, and closed intravenous (IV) catheters; and positive pressure IV catheters, central venous catheter packs, extension tubes with three-way valve, and heparin caps. Further, the company offers blood microembolus filters, disposable extracorporeal circulation tubing kits, cold cardioplegic solution perfusion apparatus, blood containers, medical surgical face masks, disinfectants, and alcohol pads. Jiangxi Sanxin Medtec Co., Ltd. was founded in 1997 and is based in Nanchang, China.
URL
http://www.sanxin-med.com/
IPO date
May 15, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,300,061
-2.69%
1,336,003
14.75%
Cost of revenue
998,318
1,036,259
Unusual Expense (Income)
NOPBT
301,743
299,744
NOPBT Margin
23.21%
22.44%
Operating Taxes
29,536
26,516
Tax Rate
9.79%
8.85%
NOPAT
272,206
273,228
Net income
206,634
11.92%
184,634
18.42%
Dividends
(59,606)
(59,104)
Dividend yield
1.51%
1.75%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
120,085
81,205
Long-term debt
83,484
50,607
Deferred revenue
43,302
43,727
Other long-term liabilities
44,442
5,140
Net debt
(332,713)
(318,416)
Cash flow
Cash from operating activities
346,149
402,176
CAPEX
(287,473)
Cash from investing activities
(425,767)
Cash from financing activities
(9,184)
35,430
FCF
72,593
182,692
Balance
Cash
362,856
361,002
Long term investments
173,425
89,227
Excess cash
471,278
383,429
Stockholders' equity
1,293,400
1,098,970
Invested Capital
1,109,143
937,131
ROIC
26.61%
30.74%
ROCE
19.03%
22.61%
EV
Common stock shares outstanding
518,659
516,587
Price
7.63
16.84%
6.53
-31.75%
Market cap
3,957,370
17.31%
3,373,470
-31.29%
EV
3,712,195
3,134,338
EBITDA
376,234
365,499
EV/EBITDA
9.87
8.58
Interest
5,323
2,947
Interest/NOPBT
1.76%
0.98%